Applied DNA Sciences Inc (APDN): Price and Financial Metrics
GET POWR RATINGS... FREE!
APDN POWR Grades
- APDN scores best on the Growth dimension, with a Growth rank ahead of 96.21% of US stocks.
- The strongest trend for APDN is in Growth, which has been heading up over the past 31 weeks.
- APDN ranks lowest in Stability; there it ranks in the 2nd percentile.
APDN Stock Summary
- For APDN, its debt to operating expenses ratio is greater than that reported by just 0.5% of US equities we're observing.
- With a year-over-year growth in debt of -100%, Applied Dna Sciences Inc's debt growth rate surpasses just 0% of about US stocks.
- Applied Dna Sciences Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -47.99%, greater than the shareholder yield of only 5.14% of stocks in our set.
- Stocks that are quantitatively similar to APDN, based on their financial statements, market capitalization, and price volatility, are DAIO, HUSA, CASI, GTYH, and EKSO.
- APDN's SEC filings can be seen here. And to visit Applied Dna Sciences Inc's official web site, go to www.adnas.com.
APDN Price Target
For more insight on analysts targets of APDN, see our APDN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $18.33 | Average Broker Recommendation | 1.5 (Moderate Buy) |
APDN Stock Price Chart Interactive Chart >
APDN Price/Volume Stats
| Current price | $6.68 | 52-week high | $14.84 |
| Prev. close | $6.59 | 52-week low | $4.95 |
| Day low | $6.42 | Volume | 84,700 |
| Day high | $6.68 | Avg. volume | 1,108,019 |
| 50-day MA | $6.42 | Dividend yield | N/A |
| 200-day MA | $7.65 | Market Cap | 50.01M |
Applied DNA Sciences Inc (APDN) Company Bio
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes applications in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications and can be used to fortify brand protection efforts, and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide definitive real-time authentication of molecular tags in the field; and CertainT Supply Chain Platform that provides proof of product claims for materials, items, or products. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and non-diagnostic COVID-19 pooled surveillance testing to detect instances of COVID-19 in defined populations under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
Latest APDN News From Around the Web
Below are the latest news stories about Applied Dna Sciences Inc that investors may wish to consider to help them evaluate APDN as an investment opportunity.
Applied DNA Sciences and A&E Introduce Anti-Counterfeiting Technology for Sustainable Sewing ThreadsApplied DNA and A&E come together to bring an innovative and economical solution to brands to authenticate and validate their products. |
Applied DNA's Veterinary COVID-19 Vaccine Candidate Induces Neutralizing Antibodies Against Three VariantsApplied DNA Sciences Inc (NASDAQ: APDN) and its program development partner, Evvivax S.R.L., have announced results from an in vitro neutralization study of sera evaluating the company's COVID-19 vaccine in felines. Data includes the trial cohort of 11 domestic felines vaccinated with the Applied DNA-Evvivax LinearDNA COVID-19 vaccine candidate against three COVID-19 variants. Data showed that all vaccinated felines produced neutralizing antibody titers against all three variants. The study show |
Applied DNA Reports Veterinary COVID-19 Vaccine Candidate Induces Neutralizing Antibodies in 100% of Trial Cohort Against B.1.1.7, P1, and B.1.526 Variants and Sets August 2021 Mink Challenge Trial LaunchApplied DNA veterinary COVID-19 vaccine induces NAbs against B.1.1.7, P1, and B.1.526 variants; Set launch of mink challenge trial for August. |
Applied DNA Adds First Summer Camp for safeCircle Pooled COVID-19 Surveillance TestingThe acquisition of safeCircle’s newest client reflects the service’s focus on profitable niche markets and the re-opening of venues for new sales. |
Thinking about buying stock in Applied DNA Sciences, Sundial Growers, New Oriental Education, BlackBerry, or Evofem Biosciences?NEW YORK , May 26, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APDN, SNDL, EDU, BB, and EVFM. Full story available on Benzinga.com |
APDN Price Returns
| 1-mo | 12.65% |
| 3-mo | -27.86% |
| 6-mo | 8.62% |
| 1-year | -7.35% |
| 3-year | -87.15% |
| 5-year | -94.78% |
| YTD | 30.98% |
| 2020 | 21.72% |
| 2019 | -73.81% |
| 2018 | -74.84% |
| 2017 | -14.05% |
| 2016 | -42.90% |
Continue Researching APDN
Want to see what other sources are saying about Applied Dna Sciences Inc's financials and stock price? Try the links below:Applied Dna Sciences Inc (APDN) Stock Price | Nasdaq
Applied Dna Sciences Inc (APDN) Stock Quote, History and News - Yahoo Finance
Applied Dna Sciences Inc (APDN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...